Xenon Pharmaceuticals: Q4 Earnings Snapshot
In this article:
BURNABY, British Columbia (AP) — BURNABY, British Columbia (AP) — Xenon Pharmaceuticals Inc. (XENE) on Thursday reported a loss of $44.7 million in its fourth quarter.
The Burnaby, British Columbia-based company said it had a loss of 64 cents per share.
The results topped Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 76 cents per share.
For the year, the company reported a loss of $182.4 million, or $2.73 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XENE at https://www.zacks.com/ap/XENE
